Evidence map›Paper›PMID 31691920›Full record

ArticleJournal of computer-aided molecular design2019

D3R Grand Challenge 4: prospective pose prediction of BACE1 ligands with AutoDock-GPU.

Diogo Santos-Martins, Jerome Eberhardt, Giulia Bianco, Leonardo Solis-Vasquez, Francesca Alessandra Ambrosio, Andreas Koch, Stefano Forli

Open access · greenAbstract read
In one paragraph

Article in Journal of computer-aided molecular design, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Accelerating AutoDock Vina with GPUs.Molecules (Basel, Switzerland) · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Accelerating AutoDock4 with GPUs and Gradient-Based Local Search.Journal of chemical theory and computation · 2021
    Article
  12. The AutoDock suite at 30.Protein science : a publication of the Protein Society · 2021
    Article
  13. Article
  14. ComparisonAvicenna journal of phytomedicine
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 3 countries.

Diogo Santos-MartinsDepartment of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, USA.ORCID 0000-0003-4622-3747
Jerome EberhardtDepartment of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, USA.
Giulia BiancoDepartment of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, USA.
Leonardo Solis-VasquezEmbedded Systems and Applications Group, Technische Universität Darmstadt, Darmstadt, Germany.
Francesca Alessandra AmbrosioDepartment of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, USA.
Andreas KochEmbedded Systems and Applications Group, Technische Universität Darmstadt, Darmstadt, Germany.ORCID 0000-0002-1164-3082
Stefano ForliDepartment of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, USA. forli@scripps.edu.ORCID 0000-0002-5964-7111
Scripps Research Institute · USTechnische Universität Darmstadt · DE

Funding

X-ray Crystallographic Fragment Screening CoreU54GM103368 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI SARAFIANOS, STEFAN G, TORBETT, BRUCE EDWARD · 2017 to 2018
$11.1M
AutoDock Suite: Next Generation Environment for Drug DesignR01GM069832 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI FORLI, STEFANO · 2004 to 2025
$10.9M
NIGMS NIH HHS R01 GM069832NIGMS NIH HHS U54 GM103368
6 · The paper itself

Abstract

In this paper we describe our approaches to predict the binding mode of twenty BACE1 ligands as part of Grand Challenge 4 (GC4), organized by the Drug Design Data Resource. Calculations for all submissions (except for one, which used AutoDock4.2) were performed using AutoDock-GPU, the new GPU-accelerated version of AutoDock4 implemented in OpenCL, which features a gradient-based local search. The pose prediction challenge was organized in two stages. In Stage 1a, the protein conformations associated with each of the ligands were undisclosed, so we docked each ligand to a set of eleven receptor conformations, chosen to maximize the diversity of binding pocket topography. Protein conformations were made available in Stage 1b, making it a re-docking task. For all calculations, macrocyclic conformations were sampled on the fly during docking, taking the target structure into account. To leverage information from existing structures containing BACE1 bound to ligands available in the PDB, we tested biased docking and pose filter protocols to facilitate poses resembling those experimentally determined. Both pose filters and biased docking resulted in more accurate docked poses, enabling us to predict for both Stages 1a and 1b ligand poses within 2 Å RMSD from the crystallographic pose. Nevertheless, many of the ligands could be correctly docked without using existing structural information, demonstrating the usefulness of physics-based scoring functions, such as the one used in AutoDock4, for structure based drug design.

Indexed as

Molecular Docking SimulationProtein BindingProtein ConformationAmyloid Precursor Protein SecretasesAspartic Acid EndopeptidasesBinding SitesComputer-Aided DesignCrystallography, X-RayDatabases, ProteinDrug DesignLigandsMacrocyclic CompoundsThermodynamicsAmyloid Precursor Protein SecretasesAspartic Acid EndopeptidasesBACE1 protein, humanLigandsMacrocyclic CompoundsAutoDockD3RDockingDrug design data resourceMacrocycle

Identifiers

PMID31691920
PMCPMC7325737
OpenAlexW2983577496

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.